Aug. 24, 2023 – At one point, nine out of every 10 opioid prescriptions in the United States were manufactured by McKinsey’s clients. The report by the Wall Street Journal found that within those vulnerable target populations was the VA. “(McKinsey) advised opioid companies including Purdue Pharma LP and Endo International PLC on how to increase sales to the VA through both new and existing channels,” the documents state. “Meanwhile, McKinsey earned at least $117 million consulting for the VA, primarily on matters related to health-care services for veterans.”